DXCM

DEXCOM INC · Healthcare · Market cap $30.3B

Insiders sold $4.7M net in the last 90 days ·7 sellers, 0 buyers· 12 of 12 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 19, 2026

Insider Buying

$1.0M

reported purchases (SEC code P)

Insider Selling

$12.8M

reported sales (SEC code S)

Unique Insiders

10

in the rolling window

Latest filing

Oct 19, 2026

Brown Michael Jon

DEXCOM INC (DXCM) has 64 SEC Form 4 filings (85 transaction rows) in the rolling window, disclosed by 10 distinct insiders. Most recent filing: Oct 19, 2026.

Inside the rolling window, 10 insiders at DEXCOM INC reported 1 open-market purchase totaling $1.0M and 28 open-market sales totaling $12.8M. The most active filer is EVP Chief Legal Compliance Off Brown Michael Jon with 8 filings. Insiders have net sold $12.0M over the trailing 6 months. The most recent open-market filing is a sale of 1,700 shares by EVP Chief Legal Compliance Off Brown Michael Jon, dated Oct 15, 2026, worth $145K.

  • Industry:Medical - Devices
  • CEO:Jacob Steven Leach
  • Employees:11,050
  • HQ:San Diego, CA, US
  • IPO:2005-04-14
Source
Sale$145KOct 19SEC ↗
Sale$221KSep 30SEC ↗
Sale$130KSep 16SEC ↗
Sale$550KSep 16SEC ↗
Sale$143KSep 16SEC ↗
Sylvain Jereme MFirst filing
Sale$303KSep 14SEC ↗
Stern SadieFirst filing
Sale$227KAug 28SEC ↗
Sale$2.4MAug 24SEC ↗
Sale$156KAug 17SEC ↗
Heller Bridgette PFirst in 3 months
Sale$89KAug 13SEC ↗
Sale$160KAug 4SEC ↗
Sale$171KAug 4SEC ↗
Sale$2.0MJul 21SEC ↗
Sale$127KJul 16SEC ↗
Sale$1.9MJul 7SEC ↗
FOLETTA MARK GFirst filing
Sale$297KJun 17SEC ↗
Sale$128KJun 17SEC ↗
Coleman JonFirst filing
Sale$359KJun 5SEC ↗
Coleman JonFirst filing
Sale$364KJun 5SEC ↗
SAYER KEVIN RFirst filing
Sale$1.9MMay 26SEC ↗
Sale$102KMay 19SEC ↗
Sale$61KMay 14SEC ↗
Sale$107KApr 16SEC ↗
Brown Michael JonFirst filing
Sale$110KMar 18SEC ↗
Heller Bridgette PFirst in 3 months
Sale$69KFeb 17SEC ↗
Showing 1–25 of 29
1 / 2

Earnings: last 7 quarters

EstimatedActual

Congress trading DXCM 55 all-time

  • DRep. Ro KhannaPurchase$1,001 - $15,0002026-05-01
  • DRep. Ro KhannaPurchase$1,001 - $15,0002026-04-13
  • RSen. John BoozmanPurchase$1,001 - $15,0002026-01-26
  • RSen. John BoozmanPurchase$1,001 - $15,0002026-01-26
  • DRep. Ro KhannaPurchase$1,001 - $15,0002026-01-29
  • RRep. Michael T. McCaulPurchase$1,001 - $15,0002025-09-22

STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.

Frequently asked questions

How many SEC Form 4 insider filings does DXCM have?

DEXCOM INC (DXCM) has 64 SEC Form 4 filings (85 transaction rows) in the rolling 365-day window, disclosed by 10 distinct insiders. Most recent filing: Oct 19, 2026.

When was the most recent SEC Form 4 filing for DXCM?

The most recent Form 4 filing for DXCM on Tracefour is dated Oct 19, 2026.

Who is the most active insider at DXCM?

The most active SEC Form 4 filer at DXCM in the rolling window is EVP Chief Legal Compliance Off Brown Michael Jon, with 8 filings.

What is the net insider flow at DXCM over the last 6 months?

Over the trailing 180 days, insiders at DXCM have net sold $12.0M based on SEC Form 4 disclosures.

What is the total insider buy and sell value at DXCM in the current window?

Inside the rolling window, insiders at DXCM bought $1.0M and sold $12.8M based on SEC Form 4 filings.

Can I get alerts for DXCM insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at DEXCOM INC (DXCM). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

DEXCOM INC is in the Healthcare sector.